Olga S. Tonkikh

Olga S. Tonkikh

Auto-generated profile, based on publicly available information

Olga S. Tonkikh

Siberian State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2021 in Medical Visualization
Verified
Journal Article
Closed access
PDF file
YSYulia Samoilova
Yulia Samoilova
MMMariia Matveeva
Mariia Matveeva
OTO. S. Tonkikh
O. S. Tonkikh
NFN. Yu. Fimushkina
N. Yu. Fimushkina
ЮСЮ. Г. Самойлова
Ю. Г. Самойлова
The purpose . To evaluate brain microcirculation using contrast and non-contrast magnetic resonance perfusion in patients with type 1 diabetes and cognitive dysfunction. Material and methods . The study complies with generally accepted ethical rules. The study included 45 patients with type 1 diabetes and cognitive dysfunction and 20 patients without. Every patient included in the study was continuously monitoring glycemia with evaluation of variability coefficients. MRI was performed using a magnetic resonance imaging scanner Signa Creator “E”, GE Healthcare, 1.5 Tl, China: methods – dynamic contrast (“Gadovist”, w/w, bolusno, 5 ml) and arterial spin marks. SPSS Statistic software package was used for statistical analysis. Results . Blood flow decreased in patients with type 1 type and cognitive dysfunction in the areas of white and gray matter of frontal, occipital and temporal lobes, and shells (p ≤ 0.05). According to perfusion data, hyperglycemia and the following glycemic variability indices have the greatest influence on cortical structures: glycemic index of prolonged glycemia increase, risk of hyperglycemia and hypoglycemia, glycemic rate of change, glycemic control quality indicator, and in case of non-contrast glycemic control quality and glycemic rate of change, risks of hypo and hyperglycemia. The main factors of changes in brain microcirculation are episodes of severe hypoglycemia in the anamnesis, duration of the disease, arterial hypertension, high cholesterol levels. No separate markers for the evaluation of cognitive disturbances in type 1 diabetes were revealed. Conclusions . The basis of microcirculatory brain disorders in type 1 diabetes is the level of HbA 1c and variability of glycemia as well as acute complications, duration of diabetes and associated conditions (arterial hypertension and hypercholesterolemia). The most important data were obtained during contrast perfusion.

15 November 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
YSYulia Samoilova
Yulia Samoilova
MMMariia Matveeva
Mariia Matveeva
DKDmitry Kudlay
Dmitry Kudlay
OTOlga S. Tonkikh
Olga S. Tonkikh
ITIvan Tolmachev
Ivan Tolmachev
КАКудлай Дмитрий Анатольевич
Кудлай Дмитрий Анатольевич
Background. Cognitive dysfunction, including mild cognitive impairment and dementia, is increasingly recognized as a serious complication of diabetes mellitus (DM) that affects patient well-being and disease management. Magnetic resonance imaging (MRI)-studies have shown varying degrees of cortical atrophy, cerebral infarcts, and deep white matter lesions. To explain the relationship between DM and cognitive decline, several hypotheses have been proposed, based on the variability of glycemia leading to morphometric changes in the brain. The ability to predict cognitive decline even before its clinical development will allow the early prevention of this pathology, as well as to predict the course of the existing pathology and to adjust medication regimens. Aim. To create a computer neural network model for predicting the development of cognitive impairment in DM on the basis of brain neuroimaging techniques. Materials and methods. The study was performed in accordance with the standards of good clinical practice; the protocol was approved by the Ethics Committee. The study included 85 patients with type 1 diabetes and 95 patients with type 2 diabetes, who were divided into a group of patients with normal cognitive function and a group with cognitive impairment. The patient groups were comparable in age and duration of disease. Cognitive impairment was screened using the Montreal Cognitive Assessment Scale. Data for glycemic variability were obtained using continuous glucose monitoring (iPro2, Libre). A standard MRI scan of the brain was performed axially, sagittally, and coronally on a Signa Creator E, GE Healthcare, 1.5 Tesla, China. For MRI data processing we used Free Surfer program (USA) for analysis and visualization of structural and functional neuroimaging data from cross-sectional or longitudinal studies, and for segmentation we used Recon-all batch program directly. All statistical analyses and data processing were performed using Statistica Statsofi software (version 10) on Windows 7/XP Pro operating systems. The IBM WATSON cognitive system was used to build a neural network model. Results. As a result of the study, cognitive impairment in DM type 1was predominantly of mild degree 36.9% (n=24) and moderate degree 30.76% (n=20), and in DM type 2 mild degree 37% (n=30), moderate degree 49.4% (n=40) and severe degree 13.6% (n=11). Cognitive functions in DM type 1 were impaired in memory and attention, whereas in DM type 2 they were also impaired in tasks of visual-constructive skills, fluency, and abstraction (p0.001). The analysis revealed differences in glycemic variability indices in patients with type 1 and type 2 DM and cognitive impairment. Standard MRI of the brain recorded the presence of white and gray matter changes (gliosis and leukoareosis). General and regional cerebral atrophy is characteristic of type 1 and type 2 DM, which is associated with dysglycemia. When building neural network models for type 1 diabetes, the parameters of decreased volumes of the brain regions determine the development of cognitive impairment by 93.5%, whereas additionally, the coefficients of glycemic variability by 98.5%. The same peculiarity was revealed in type 2 DM 95.3% and 97.9%, respectively. Conclusion. In DM type 1 and type 2 with cognitive impairment, elevated coefficients of glycemic variability are more frequently recorded. This publication describes laboratory and instrumental parameters as potential diagnostic options for effective management of DM and prevention of cognitive impairment. Neural network models using glycemic variability coefficients and MR morphometry allow for predictive diagnosis of cognitive disorders in both types of diabetes.

13 December 2021 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
OOO.A. Oleynik
O.A. Oleynik
DKDmitry Kudlay
Dmitry Kudlay
YSYulia Samoilova
Yulia Samoilova
MMMariia Matveeva
Mariia Matveeva
DPD.V. Podchinenova
D.V. Podchinenova
ITIvan Tolmachev
Ivan Tolmachev
The problem of obesity among children and adolescents is becoming more and more significant every year due to the increasing prevalence and its complications. Altered brain functioning is noted in obesity and contribute to eating behavior as well as the brain-gastrointestinal tractvisceral fat axis. This literature review is focuses on the issues of neuroimaging studies of the brain in obesity in childhood and the possibilities of various methods in the diagnosis and prediction of disorders. Medline and Cochrane Central Register of Controlled Trials (CENTRAL) databases from 2000 to 2021 were used for the literature search.

20 March 2021 in Diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
YSYulia Samoilova
Yulia Samoilova
MMMariia Matveeva
Mariia Matveeva
OTO. S. Tonkikh
O. S. Tonkikh
OLO. P. Leuman
O. P. Leuman
OGO. M. Gerget
O. M. Gerget
ЮСЮ. Г. Самойлова
Ю. Г. Самойлова
Objective. To evaluate neurovascularization using contrast and non-contrast magnetic resonance perfusion. Materials and methods. 140 patients with type 2 diabetes with and without cognitive impairment were included in the study. We assessed the variability of glycemia, magnetic resonance imaging (MRI): contrast and non-contrast. Results: brain neurovascularization change is associated with glycemia variability, with contrast advantage revealed in the contrast study. Microcirculation disorder occurs in both cortical (grey matter area) and subcortical structures. The greatest influence on brain vascularization disturbance in type 2 diabetes was revealed in terms of age, body mass index, arterial hypertension. Hyperglycemia and its duration, as well as hypoglycemia, control quality, average amplitude of oscillation, average time in the target range determined the change of vascularization. Conclusions. Understanding the pathogenesis of microcirculation disorders and the role of glycemia variability in the brain in type 2 diabetes, it is possible to correct the glycemic curve in time and eliminate modifiable risk factors (body mass index, arterial hypertension) affecting the development of cognitive disorders.

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
YSYulia Samoilova
Yulia Samoilova
MMMariia Matveeva
Mariia Matveeva
OOOxana Oleynik
Oxana Oleynik
OTO.S. Tonkikh
O.S. Tonkikh
DKDmitry Kudlay
Dmitry Kudlay
IVI.N. Vorozhtsova
I.N. Vorozhtsova
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить связь структуры белого вещества головного мозга, нейроваскуляризации и когнитивных функций у детей и подростков с ожирением. МАТЕРИАЛ И МЕТОДЫ Обследованы 64 пациента с ожирением в возрасте 12—17 лет и 54 ребенка без избытка массы тела. Проведены общеклиническое обследование, нейропсихологическое тестирование (тест Равена с расчетом коэффициента интеллекта — IQ, Монреальская шкала оценки когнитивных функций (MoCA), тест Рея, версии 1 и 2), МРТ трактография и бесконтрастная перфузия головного мозга. РЕЗУЛЬТАТЫ Дети и подростки с ожирением имели снижение баллов как по данным тестов MoCA и Равена, так и в пересчете на IQ, при этом по тесту Рея, версия 1 в двух группах были значимые различия, а по версии 2 результаты были сопоставимы. Перфузионный анализ показал снижение васкуляризации в области белого вещества затылочной доли слева и ее повышение в зоне височной доли также слева. При оценке белого вещества, по данным МР-трактографии, отмечалось снижение фракционной анизотропии в области крючковидного пучка справа и слева, переднего и заднего комиссуральных трактов. Данные изменения коррелировали с результатами нейропсихологического тестирования. ЗАКЛЮЧЕНИЕ У детей и подростков с ожирением отмечалось нарушение целостности белого вещества и васкуляризации головного мозга, ассоциированное с нарушением когнитивных функций.

5 September 2020 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
YSYu. G. Samoilova
Yu. G. Samoilova
OLO. P. Leyman
O. P. Leyman
OTO. S. Tonkih
O. S. Tonkih
MMMariia Matveeva
Mariia Matveeva
DKDmitry Kudlay
Dmitry Kudlay
ЮСЮ. Г. Самойлова
Ю. Г. Самойлова
Aim. To study the features of biochemical and morphometric parameters in patients with type 2 diabetes (T2D) and cognitive impairment (CI).Material and methods. The experimental group included 72 patients with CI and T2D, the control group − 20 patients with T2D and without CI. We used the Montreal Cognitive Scale (MoCA) to assess the presence of CI. We also evaluated the levels of 1,5-anhydroglucitol (1,5-AG), continuous glucose monitoring (CGM), and data of brain magnetic resonance imaging (MRI).Results. We revealed that patients with T2D and CI have high HbA1c levels, but there was no significant difference of 1,5-AG levels between the groups. In patients with CI, we also established a decrease in gray and white matter surface area, as well as subcortical structures (the hippocampus, nucleus accumbens and putamen on both sides; the amygdala and globus pallidus on the right). The severity of CI correlated with polyneuropathy severity. In patients with proliferative retinopathy, there was a decrease in the volume of the caudate nucleus, globus pallidus, putamen and nucleus accumbens. Conclusion. The study revealed that patients with T2D with CI have worse levels of carbohydrate metabolism parameters, as well as a decrease in the cortical and subcortical brain structures.